Talkdesk and Epic enter new collaboration with the launch of Epic’s Pals program

2 years ago

Industry-leader in electronic health record (EHR) software deepens collaboration with Talkdesk to co-innovate on integrated patient experience solutionsSAN FRANCISCO--(BUSINESS WIRE)--#CX--Talkdesk®,…

PicnicHealth Announces Entry into Market for Oncology-Focused Real-World Data

2 years ago

Company announces multi-year strategic partnership with AstraZeneca to accelerate early breast cancer evidence development and researchSAN FRANCISCO--(BUSINESS WIRE)--PicnicHealth, a patient-centered…

IRLAB Secures Full Ownership of the Mesdopetam Project and Continues Product Development

2 years ago

GOTHENBURG, SE / ACCESSWIRE / August 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for…

IRLAB Provides Update on Mesdopetam’s Phase IIb Study Data and the Plans Toward Phase III

2 years ago

GOTHENBURG, SE / ACCESSWIRE / August 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for…

AlayaCare Welcomes Seasoned Executive Rhonda Bosch as Senior Vice President of Customer Success

2 years ago

TORONTO, ON / ACCESSWIRE / August 21, 2023 / AlayaCare, an industry-leading end-to-end platform for home-based care today, announced that…

The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides

2 years ago

SHELTON, CT / ACCESSWIRE / August 21, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development…

Bethany L. Sensenig Joins Supernus’ Board of Directors

2 years ago

ROCKVILLE, Md., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…

Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing Patterns of Heart Failure Diagnoses at the European Society of Cardiology (ESC) Congress 2023

2 years ago

INPEFA recently approved by FDA for treatment of heart failure THE WOODLANDS, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon…

RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS

2 years ago

WEST PALM BEACH, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan…

NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards

2 years ago

Award Acknowledges Excellence in Digital Marketing EffortsMALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical…